References
- Qureshi AA, Abate LE, Yosipovitch G, et al. A systematic review of evidence-based treatments for prurigo nodularis. J Am Acad Dermatol. 2019;80(3):756–764.
- Rambhia PH, Levitt JO. Recalcitrant prurigo nodularis treated successfully with dupilumab. JAAD Case Rep. 2019;5(5):471–473.
- van Laarhoven AIM, van der Sman-Mauriks IM, Donders ART, et al. Placebo effects on itch: a meta-analysis of clinical trials of patients with dermatological conditions. J Invest Dermatol. 2015;135(5):1234–1243.
- Phan N, Blome C, Fritz F, et al. Assessment of pruritus intensity: prospective study on validity and reliability of the visual analogue scale, numerical rating scale and verbal rating scale in 471 patients with chronic pruritus. Acta Derm Venerol. 2012;92(5):502–507.
- Trevi Therapeutics, Inc Initial Public Offering. Published 2019 [cited 2019 Apr 26]. Available from: https://www.sec.gov/Archives/edgar/data/1563880/000119312519099340/d643194ds1.htm.